Linking Performance and Corporate Value through Stock-Compensation-Type Stock Options
First written in FY2017-Q1. 24 of 25 entries say "Advanced", first in FY2018-Q1. Latest entry: 2026-08-10.
- FY2026AdvancedAnnual report
「Series 14 Stock Acquisition Rights (Class B Stock Acquisition Rights) Number of stock acquisition rights (units)* 2,938 Class, description and number of shares underlying the stock acquisition rights (shares)* Common stock 293,800」
Of the Series 14 Class B stock acquisition rights approved in July 2025, 293,800 shares were issued during the fiscal year. The rights were granted to directors and executive officers, including 21 directors and 5 executive officers of group companies. - FY2026-H1AdvancedAnnual report
「Series 14 Stock Acquisition Rights (Class B Stock Acquisition Rights)」
Based on a resolution dated 28 July 2025, 3,044 stock acquisition rights representing 304,400 shares were issued to 2 company directors, 2 company executive officers, 21 directors of group companies and 5 executive officers of group companies. The exercise period runs from 27 August 2025 to 26 August 2065, and new grants of stock options structured as share-based compensation continued to take concrete form. - FY2025AdvancedAnnual report
「Series 12 Class A Stock Acquisition Rights Common stock: 455,100 shares Series 13 Class B Stock Acquisition Rights Common stock: 150,300 shares」
As of 30 July 2024, 455,100 Class A shares and 150,300 Class B shares were granted to the directors and executive officers of the company and its group companies. Series 12 Class A stock acquisition rights were exercised for 452,400 shares, bringing the share-based compensation program to the exercise stage. - FY2025-H1AdvancedAnnual report
「Series 12 Stock Acquisition Rights (Class A Stock Acquisition Rights) Number of stock acquisition rights (units)* 4,551 Class, description and number of shares underlying the stock acquisition rights (shares)* Common stock 455,100 Series 13 Stock Acquisition Rights (Class B Stock Acquisition Rights) Number of stock acquisition rights (units)* 1,503 Class, description and number of shares underlying the stock acquisition rights (shares)* Common stock 150,300」
Based on a resolution dated 8 July 2024, stock acquisition rights for 455,100 Class A shares under Series 12 and 150,300 Class B shares under Series 13 were issued to the directors and executive officers of the company and its group companies. New grants of stock options structured as share-based compensation continued to take concrete form. - FY2024AdvancedAnnual report
「For the 11th-series Class A share acquisition rights, 289,900 shares vested and 289,900 shares were exercised.」
Series 11 Class A stock acquisition rights progressed through vesting and exercise for 289,900 shares, demonstrating the implementation of stock options structured as share-based compensation. - FY2024-Q2AdvancedAnnual report
「11th-series share acquisition rights (Class A share acquisition rights) Resolution date 3 July 2023 Categories and number of grantees (people) Company directors: 2 Subsidiary directors: 6 Subsidiary executive officers: 9 Number of share acquisition rights (rights)* 2,899」
For the 11th-series Class A and 12th-series Class B share acquisition rights whose issuance resolution was reported in FY2024-Q1, the issue details at issuance on 1 August 2023 were disclosed. The Company granted 2,899 Class A rights representing 289,900 shares and 1,767 Class B rights representing 176,700 shares to its directors, subsidiary directors, and subsidiary executive officers. The exercise period was set from 2 August 2023 to 1 August 2063. - FY2024-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 3 July 2023, the Company resolved, pursuant to Articles 236, 238, and 240 of the Companies Act, to issue share acquisition rights as stock options structured as share-based compensation to directors and executive officers of the Company and its subsidiaries.」
The Company resolved to issue 2,899 Class A rights representing 289,900 shares and 1,767 Class B rights representing 176,700 shares, for a total of 4,666 rights representing 466,600 shares, to directors and executive officers of the Company and its subsidiaries. The initiative linking performance and share value to executive compensation and other remuneration progressed to a new grant resolution. - FY2023AdvancedAnnual report
「Other (exercise of share acquisition rights), 756,200 shares」
The tenth-series Class A share acquisition rights representing 756,200 shares were exercised, resulting in the disposal of treasury shares. The continued grant of the 11th-series Class B share acquisition rights representing 188,000 shares was also disclosed, with the initiative linking performance and corporate value to executive compensation and other remuneration progressing through both the exercise and new grant stages. - FY2023-Q2AdvancedAnnual report
「Tenth-series share acquisition rights (Class A share acquisition rights) Resolution date 29 July 2022 Categories and number of grantees (people) Company directors: 7 Company executive officers: 7 Number of share acquisition rights (rights)* 7,562」
The tenth-series Class A share acquisition rights representing 756,200 shares and the 11th-series Class B share acquisition rights representing 188,000 shares were issued on 23 August 2022 to 7 directors and 7 executive officers. The initiative linking performance and share value to executive compensation and other remuneration progressed to the issuance stage. - FY2023-Q1AdvancedAnnual report
「The purpose is to clarify further the linkage between the company’s performance and share value and director compensation and salaries, thereby further increasing motivation to contribute to improved performance and corporate value over the medium to long term.」
At a meeting of the Board of Directors held on 29 July 2022, the Company resolved to issue share acquisition rights representing a total of 944,200 shares to 7 directors and 7 executive officers: 7,562 Class A rights representing 756,200 shares and 1,880 Class B rights representing 188,000 shares. - FY2022AdvancedAnnual report
「Other (exercise of share acquisition rights), 396,100」
For the stock options structured as share-based compensation, 396,100 treasury shares were disposed of through the exercise of rights in the first through eighth series and other series. Grants of 257,700 shares under the ninth-series Class A rights and 158,100 shares under the tenth-series Class B rights were also disclosed, with the initiative linking compensation to performance and corporate value progressing through both the exercise and continued grant stages. - FY2022-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 12 July 2021, the Company resolved, pursuant to Articles 236, 238, and 240 of the Companies Act, to issue share acquisition rights as stock options structured as share-based compensation to the Company’s directors and executive officers. Based on this resolution, the Board of Directors resolved at its meeting held on 30 July 2021 to grant stock options structured as share-based compensation.」
As a subsequent event, the Company disclosed a resolution to grant Class A share acquisition rights representing 257,700 shares and Class B share acquisition rights representing 158,100 shares, to directors and executive officers. The initiative linking compensation and other executive remuneration to performance and share value continued to take concrete form. - FY2021AdvancedAnnual report
「Disposal of treasury shares: Other (exercise of share acquisition rights), 242,400 shares」
For the first through eighth series of stock options structured as share-based compensation, approximately 30,000 shares in each series, totaling 242,400 shares, were exercised, resulting in the disposal of treasury shares. The grant of 159,600 shares under the ninth-series Class B share acquisition rights also continued. - FY2021-Q2AdvancedAnnual report
「Ninth-series share acquisition rights (Class B share acquisition rights)」
For the stock options structured as share-based compensation whose approval and grant were reported in FY2021-Q1, the specific issue details at issuance on 1 August 2020 were disclosed: 399 rights representing 159,600 underlying shares, granted to 7 directors and 5 executive officers, with an exercise period from 2 August 2020 to 1 August 2060. - FY2021-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 13 July 2020, the Company resolved, pursuant to Articles 236, 238, and 240 of the Companies Act, to issue share acquisition rights as stock options structured as share-based compensation to the Company’s directors and executive officers. Based on this resolution, the Board of Directors resolved at its meeting held on 31 July 2020 to grant stock options structured as share-based compensation.」
The Company resolved to grant 399 Class B share acquisition rights representing 159,600 underlying shares to 7 directors and 5 executive officers. The purpose was to link compensation and other remuneration to performance and share value, and the exercise period was set from 2 August 2020 to 1 August 2060. - FY2020AdvancedAnnual report
「The compensation structure is designed so that compensation is determined based on base compensation as well as individual performance and Company performance.」
In addition to continuing the stock options structured as share-based compensation, the Company disclosed a compensation structure incorporating individual performance and Company performance, as well as a decision-making process informed by the Compensation Committee. The eighth-series share acquisition rights represent 156,000 underlying shares. - FY2020-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 1 July 2019, the Company resolved, pursuant to Articles 236, 238, and 240 of the Companies Act, to issue share acquisition rights as stock options structured as share-based compensation to the Company’s directors and executive officers. Based on this resolution, the Board of Directors resolved at its meeting held on 29 July 2019 to grant stock options structured as share-based compensation.」
The Company resolved to grant 390 Class B share acquisition rights representing 156,000 underlying shares to 7 directors and 6 executive officers. The allotment date was 30 July 2019, and the exercise period was from 31 July 2019 to 30 July 2059, advancing the initiative linking compensation to performance and share value to a new issuance and grant stage. - FY2019AdvancedAnnual report
「Seventh-series Class B share acquisition rights: common shares, 156,000 Eighth-series Class A share acquisition rights: common shares, 180,800」
For the seventh-series Class B and eighth-series Class A share acquisition rights granted in August 2018, 180,800 Class A shares vested and 163,600 shares were exercised. The share-based compensation initiative intended to link compensation to performance and corporate value progressed to the vesting and exercise stages. - FY2019-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
Based on the resolution of 2 August 2018, 452 Class B rights in the seventh series and 410 Class A rights in the eighth series, for a total of 862 share acquisition rights, were issued. The total number of underlying shares was 344,800, bringing the existing stock option program structured as share-based compensation through to the issuance stage. - FY2019-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 2 August 2018, the Company resolved, pursuant to Articles 236, 238, and 240 of the Companies Act, to issue share acquisition rights as stock options structured as share-based compensation to the Company’s directors and executive officers.」
The Company resolved to issue 452 Class A and 410 Class B share acquisition rights, for a total of 862 rights. The total number of underlying shares was 344,800, and the purpose was to link compensation to performance and share value. - FY2018-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
The issue details disclosed for the stock options structured as share-based compensation, whose approval and grant were reported in the previous quarterly report, comprised 353 Class A rights (141,200 shares) and 320 Class B rights (128,000 shares), for a total of 673 rights (269,200 shares). - FY2018-Q1AdvancedAnnual report
「At a meeting of the Board of Directors held on 27 June 2017, the Company resolved, pursuant to Articles 236, 238, and 240 of the Companies Act, to issue share acquisition rights as stock options structured as share-based compensation to the Company’s directors and executive officers. Based on this resolution, the Board of Directors resolved at its meeting held on 10 July 2017 to grant stock options structured as share-based compensation.」
The Company resolved to issue and grant new stock options structured as share-based compensation. The plan provided for the grant of 353 Class A rights and 320 Class B rights, for a total of 673 rights representing 269,200 shares, to 6 directors and 5 executive officers, giving concrete form to the existing initiative linking compensation to performance and share value. - FY2017-Q1First statedAnnual report
「The purpose is to clarify further the linkage between the company’s performance and share value and director compensation and salaries, thereby further increasing motivation to contribute to improved performance and corporate value over the medium to long term.」
Share acquisition rights were granted on 26 July 2016 to directors, executive officers, Audit & Supervisory Board Members, and representative directors of Group companies. The sixth series comprised 382 share acquisition rights, with each right representing 400 shares.